Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Mercury Insurance
MCY
$5.94B
| $2.93M | ﹤0.01% |
46,557
+35,470
| +320% | +$2.11M |
|
|
AMWD
2502
DELISTED
American Woodmark
AMWD
| $2.93M | ﹤0.01% |
31,316
+22,804
| +268% | +$2.05M |
|
2503
Driven Brands
DRVN
$2.4B
| $2.93M | ﹤0.01% |
205,068
+54,277
| +36% | +$743K |
|
2504
Armstrong World Industries
AWI
$7.58B
| $2.92M | ﹤0.01% |
22,233
+6,889
| +45% | +$852K |
|
2505
Magnite
MGNI
$2.8B
| $2.92M | ﹤0.01% |
210,598
+164,093
| +353% | +$2.24M |
|
2506
PUT
Abbott
ABT
$185B
| $2.91M | ﹤0.01% |
+25,500
| New | +$2.8M |
|
2507
RxSight
RXST
$260M
| $2.91M | ﹤0.01% |
58,786
+46,783
| +390% | +$2.4M |
|
2508
CALL
Prologis
PLD
$135B
| $2.9M | ﹤0.01% |
23,000
-37,400
| -62% | -$4.64M |
|
|
CIM
2509
Chimera Investment
CIM
$1.06B
| $2.9M | ﹤0.01% |
183,295
+137,655
| +302% | +$2.06M |
|
2510
Collegium Pharmaceutical
COLL
$1.15B
| $2.9M | ﹤0.01% |
75,052
+45,291
| +152% | +$1.62M |
|
2511
Deluxe
DLX
$1.23B
| $2.89M | ﹤0.01% |
148,447
+62,715
| +73% | +$1.31M |
|
2512
Sabre
SABR
$779M
| $2.89M | ﹤0.01% |
786,425
+367,778
| +88% | +$1.14M |
|
2513
Nurix Therapeutics
NRIX
$2.41B
| $2.88M | ﹤0.01% |
128,344
+56,190
| +78% | +$1.27M |
|
2514
IPG Photonics
IPGP
$3.7B
| $2.88M | ﹤0.01% |
38,787
+11,562
| +42% | +$864K |
|
2515
Winnebago Industries
WGO
$885M
| $2.88M | ﹤0.01% |
49,572
+34,917
| +238% | +$2M |
|
2516
Sally Beauty Holdings
SBH
$1.54B
| $2.88M | ﹤0.01% |
212,159
+56,879
| +37% | +$676K |
|
|
MRSH
2517
CALL
Marsh
MRSH
$92B
| $2.88M | ﹤0.01% |
12,900
| – | – |
|
2518
InMode
INMD
$882M
| $2.88M | ﹤0.01% |
169,630
+90,173
| +113% | +$1.52M |
|
2519
Center Bancorp
CNOB
$1.68B
| $2.87M | ﹤0.01% |
114,708
+39,249
| +52% | +$902K |
|
2520
RLI Corp
RLI
$5.62B
| $2.87M | ﹤0.01% |
37,078
-11,720
| -24% | -$866K |
|
2521
Golub Capital BDC
GBDC
$3.44B
| $2.87M | ﹤0.01% |
190,132
+59,443
| +45% | +$897K |
|
2522
Rocket Pharmaceuticals
RCKT
$372M
| $2.86M | ﹤0.01% |
154,974
+24,177
| +18% | +$495K |
|
2523
Gentherm
THRM
$1.28B
| $2.86M | ﹤0.01% |
61,466
+43,108
| +235% | +$2.14M |
|
2524
Weave Communications
WEAV
$537M
| $2.86M | ﹤0.01% |
223,503
+54,019
| +32% | +$570K |
|
2525
Global Net Lease
GNL
$1.83B
| $2.86M | ﹤0.01% |
339,701
+257,310
| +312% | +$2.16M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.